The Utility of Perirenal Fat in Determining the Risk of Onset and Progression of Diabetic Kidney Disease

Table 4

Cox regression models for risk factors associated with the endpoint.

Model	Variable	HR	95% CI
Model 1	Sex	1.80	0.91, 3.56	0.090
	Age	1.02	0.93, 1.04	0.186
	PFT	2.91	1.16, 7.30	0.023
Model 2	Sex	1.53	0.72, 3.28	0.147
	Age	1.040	0.94, 1.11	0.424
	Hypertension	2.57	0.77, 4.20	0.113
	Diabetes course	1.13	0.94, 1.27	0.201
	Insulin therapy	0.48	0.25, 0.93	0.029
	Antihypertensive drugs	0.25	0.08, 0.83	0.024
	Hypolipidemic therapy	0.39	0.11, 1.11	0.152
	PFT	2.89	1.14, 7.50	0.026
Model 3	Sex	1.39	0.66, 2.21	0.440
	Age	1.01	0.99, 1.03	0.254
	Diabetes course	1.04	0.98, 1.05	0.511
	Hypertension	2.26	1.18, 3.38	0.014
	Insulin therapy	0.41	0.21, 0.67	0.005
	Antihypertensive drugs	1.44	0.81, 2.04	0.866
	Hypolipidemic therapy	2.11	0.41, 3.83	0.890
	PFT	2.83	1.34, 4.88	<0.001
	BMI	1.04	0.97, 1.11	0.288
	PFT/BMI	1.20	1.03, 1.40	0.017
	HbA1C	1.20	1.11, 1.26	<0.001
	ALB	1.03	0.98, 1.08	0.259
	eGFR	0.98	0.97, 0.99	<0.001
	UACR	1.06	1.01, 1.12	0.026

Hypertension: history of hypertension; HbA1C: glycated hemoglobin ratio; FPG: fasting plasma glucose; UACR: urinary creatinine protein ratio; ALB: serum albumin; urea: serum urea nitrogen; SCr: blood creatinine; UA: blood uric acid; Tch: total serum cholesterol; TG: triglycerides; HDL: serum high-density lipoprotein; LDL: serum low-density lipoprotein; eGFR: predicted glomerular filtration rate; PFT: perirenal fat thickness.